Ranexa drug class?

What drug class is Ranexa?

Ranexa (ranolazine) is an antianginal medicine. It is used to treat chronic (long-term) angina, meaning it helps reduce the frequency of angina attacks in people with coronary artery disease.

What is Ranexa’s mechanism of action?

Ranolazine is known for its effects on cardiac electrical activity. It works by altering sodium- and calcium-related ion currents in heart cells, which helps stabilize cardiac conduction and can improve symptoms in chronic angina.

How does Ranexa compare with other angina drug classes?

Ranexa is different from the most common first-line angina medicines such as beta blockers, calcium channel blockers, and nitrates. Those drugs mainly reduce heart rate and/or dilation of blood vessels. Ranexa targets heart cell electrical properties, which is why it can be used when angina is not adequately controlled with other therapies.

Is Ranexa a beta blocker, nitrate, or calcium channel blocker?

No. Ranexa (ranolazine) is not a beta blocker, not a nitrate, and not a calcium channel blocker. It belongs to the antianginal class with a distinct electrical mechanism.

Sources

[1] https://www.drugpatentwatch.com/